Reduced plasma level of diazepam-binding inhibitor (DBI) in patients with morbid obesity

Detalles Bibliográficos
Autores principales: Siejka, Agnieszka, Jankiewicz-Wika, Joanna, Stępień, Henryk, Fryczak, Jolanta, Świętosławski, Jacek, Komorowski, Jan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2015
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4512568/
https://www.ncbi.nlm.nih.gov/pubmed/25561371
http://dx.doi.org/10.1007/s12020-014-0522-5
_version_ 1782382526996676608
author Siejka, Agnieszka
Jankiewicz-Wika, Joanna
Stępień, Henryk
Fryczak, Jolanta
Świętosławski, Jacek
Komorowski, Jan
author_facet Siejka, Agnieszka
Jankiewicz-Wika, Joanna
Stępień, Henryk
Fryczak, Jolanta
Świętosławski, Jacek
Komorowski, Jan
author_sort Siejka, Agnieszka
collection PubMed
description
format Online
Article
Text
id pubmed-4512568
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-45125682015-07-24 Reduced plasma level of diazepam-binding inhibitor (DBI) in patients with morbid obesity Siejka, Agnieszka Jankiewicz-Wika, Joanna Stępień, Henryk Fryczak, Jolanta Świętosławski, Jacek Komorowski, Jan Endocrine Research Letter Springer US 2015-01-06 2015 /pmc/articles/PMC4512568/ /pubmed/25561371 http://dx.doi.org/10.1007/s12020-014-0522-5 Text en © The Author(s) 2014 https://creativecommons.org/licenses/by/4.0/ Open AccessThis article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.
spellingShingle Research Letter
Siejka, Agnieszka
Jankiewicz-Wika, Joanna
Stępień, Henryk
Fryczak, Jolanta
Świętosławski, Jacek
Komorowski, Jan
Reduced plasma level of diazepam-binding inhibitor (DBI) in patients with morbid obesity
title Reduced plasma level of diazepam-binding inhibitor (DBI) in patients with morbid obesity
title_full Reduced plasma level of diazepam-binding inhibitor (DBI) in patients with morbid obesity
title_fullStr Reduced plasma level of diazepam-binding inhibitor (DBI) in patients with morbid obesity
title_full_unstemmed Reduced plasma level of diazepam-binding inhibitor (DBI) in patients with morbid obesity
title_short Reduced plasma level of diazepam-binding inhibitor (DBI) in patients with morbid obesity
title_sort reduced plasma level of diazepam-binding inhibitor (dbi) in patients with morbid obesity
topic Research Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4512568/
https://www.ncbi.nlm.nih.gov/pubmed/25561371
http://dx.doi.org/10.1007/s12020-014-0522-5
work_keys_str_mv AT siejkaagnieszka reducedplasmalevelofdiazepambindinginhibitordbiinpatientswithmorbidobesity
AT jankiewiczwikajoanna reducedplasmalevelofdiazepambindinginhibitordbiinpatientswithmorbidobesity
AT stepienhenryk reducedplasmalevelofdiazepambindinginhibitordbiinpatientswithmorbidobesity
AT fryczakjolanta reducedplasmalevelofdiazepambindinginhibitordbiinpatientswithmorbidobesity
AT swietosławskijacek reducedplasmalevelofdiazepambindinginhibitordbiinpatientswithmorbidobesity
AT komorowskijan reducedplasmalevelofdiazepambindinginhibitordbiinpatientswithmorbidobesity

Ejemplares similares